Newsbenzinga
Astrazeneca Secures FDA Approval for New Breast Cancer Treatment
· Published
Article summary
AstraZeneca secured FDA approval for its breast cancer drug Etcamah and reported positive Phase 3 trial data for lung cancer and COPD.
An excerpt from the original article.
Comments —
Loading comments…